This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopai [2025/02/12 23:26] – jfpothier | bacteria:t3e:xopai [2025/07/13 23:25] (current) – jfpothier | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== The Type III Effector XopAI from // | ====== The Type III Effector XopAI from // | ||
- | Author: [[https:// | + | Author: [[https:// |
Class: XopAI\\ | Class: XopAI\\ | ||
Line 19: | Line 19: | ||
Based on homology to effectors from // | Based on homology to effectors from // | ||
+ | |||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
Line 26: | Line 27: | ||
Using microarrays, | Using microarrays, | ||
+ | |||
=== Phenotypes === | === Phenotypes === | ||
Line 33: | Line 35: | ||
The XopAI N‐terminal domain contains a myristoylation motif, which was previously identified in several T3Es of //P. syringae//, indicating that effectors with this N‐terminal domain are targeted to host cellular membranes (White //et al.//, 2009). | The XopAI N‐terminal domain contains a myristoylation motif, which was previously identified in several T3Es of //P. syringae//, indicating that effectors with this N‐terminal domain are targeted to host cellular membranes (White //et al.//, 2009). | ||
+ | |||
=== Enzymatic function === | === Enzymatic function === | ||
Line 40: | Line 43: | ||
Structural homologs of XopAI are, among others, the HopU1 (// | Structural homologs of XopAI are, among others, the HopU1 (// | ||
+ | |||
=== Interaction partners === | === Interaction partners === | ||
Line 49: | Line 53: | ||
XopAI homologs were also found in //X. citri// pv. //bilvae// and //X. citri// pv. // | XopAI homologs were also found in //X. citri// pv. //bilvae// and //X. citri// pv. // | ||
+ | |||
=== In other plant pathogens/ | === In other plant pathogens/ | ||
Line 75: | Line 80: | ||
White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | ||
+ | |||
+ | ===== Acknowledgements ===== | ||
+ | |||
+ | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||
+ | |||